Scaling up ART in Sénégal: specifics needs for strategic information Mame Awa Toure MD, MSc AIDS/STI Division, MOH Senegal.

Slides:



Advertisements
Similar presentations
Planning for Transition from Opti on B to B+: Rwanda Experience MUGWANEZA Placidie, Coordinator of HIV prevention Unit/RBC/MOH ART in pregnancy, breastfeeding.
Advertisements

Targeting Criteria in National ARV Programs: Mexico, Senegal, and Uganda Catherine Chanfreau, MD, MPH Sara Bennett, PhD Abt Associates, Bethesda, USA XV.
Overview/Importance of HMIS
A Guide to Monitoring and Evaluating HIV/AIDS Care and Support.
Expanding IMAI: Driving a decentralized approach in Senegal and in other West and Central African Countries Papa Salif SOW MD, MSc Department of Infectious.
Group III: Demand Forecasting
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
1 Framework for Universal Access to HIV Prevention, Treatment and Care in the Health Sector Presented by Professor Charles Gilks, Director, Co-ordinator.
Harmonization of Reporting Requirements Tanzania
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Contribution of Economics to Operational Research for Evaluation of Scaling Up Access to HIV Care & Treatment in Developing Countries Presentation by Pr.
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
Thailand Experiences with M&E on ART Sanchai Chasombat MD. Panumad Yarnwaidsakul MD. Department of Disease Control,Ministry of Public Health Thailand July.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
World Health Organization Department of HIV/AIDS Estimates of ARV Treatment Needs
Towards a model M&E system for AIDS programs Kampala April
February Dakar, Senegal
Family Planning/HIV Integration in a Large PEPFAR HIV Program – the ZPCT II Experience Prisca Kasonde MD, MMed, MPH Director Technical Support, ZPCT II/FHI.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Size and Population Density of Botswana 2009 estimate: 1.99m 61% aged % growth rate 0.85% death rate 0.5% migration 62yrs life expectancy 60%
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.
Prevention of Mother-to-Child Transmission of HIV in Ghana
1 Measuring adherence using electronic dispensing data: nationwide electronic monitoring in Namibia Dr. David Mabirizi – Country Director MSH Namibia Third.
Achieving excellence in the supply chain workforce
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
Proposed Priority Actions By NSF Goals (before group work) By Rose Nalwadda 1 st February 2006.
Dr. Philippe Chiliade Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Lessons learned and challenges in scaling up Pediatric.
1 Partnering to Strengthen Local Efforts Can Help Us Get to Six Million on ART Anja Giphart, MD MPH Vice President, Program Implementation Elizabeth Glaser.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
From HIV Testing to Treatment: Operations Research to Improve ARV Treatment Programs Treatment Acceleration Program Meeting November 30, 2006 Mark Micek,
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
World Vision Experiences in Making ART Treatment Affordable and Available Dr. Daniel J Malleboyina M.B.B.S, MBA, MPH Regional Advisor HIV & AIDS- Asia.
FREE STATE DEPARTMENT OF HEALTH Presentation on the Status of Conditional Grants Public Hearings on Conditional Grants 03 May 2006.
Ministry of Public Health & Population Haiti Toward Universal Care HIV/AIDS October 2010.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Public-Private Partnership to Scale Up and Sustain TB and HIV Care in Ethiopia Tesfai Gabre-Kidan, MD Country Director, Private Health Sector Abt Associates.
Aids treatment on the field Experiences from CAMEROON Swiss AIDS platform Aidsfocus Bern, April 2004 Béata UMUBYEYI.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
Peeramon Ningsanond MD. Bureau of AIDS TB STI, DDC, MOPH Thailand
TB- HIV Collaborative activities in Romania- may 2006 status
Ministry of Health Republic of Indonesia
Zimbabwe’s shift towards treat all: national country context
Current harm reduction program at outreach
iCCM Experience Malawi
Expanding ARV treatment in developing countries: Issues and Prospects
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Data Collection/Cleaning/Quality Processes MISAU Experience in Mozambique September 2017.
China 2010 UNGASS Country Progress Report
Vietnam Investment and Finance for TB
Presentation for Second Meeting of the Global TB/HIV Working Group
Collaborative TB/HIV activities in European Region
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
Presentation transcript:

Scaling up ART in Sénégal: specifics needs for strategic information Mame Awa Toure MD, MSc AIDS/STI Division, MOH Senegal

Introduction Senegal: a west African country Area: km² Population estimated to 10 millions 11 regions and 30 departments/ provinces. Resources constrained settings: GDP of 500$ US. Concentrated HIV epidemic Low HIV prevalence in general population less than 2% 5-20% in high risk group

The Senegalese Initiative for Access to ARVs : ISAARV A Governmental initiative late 1997 Political commitment : increasing annual subsidy Collaboration of ANRS: technical support, project design First step : Pilot study Building up a model according limited resources Evaluation before extension (collaboration with ANRS) Second step : scale up for nationwide access

Accelerating phase of ISAARV  Political comittement Government subsidy increased Subsidy included to the national budget line Credit IDA : MAP  Expanding Fund and Partnership for ARV program  government,  WB, GF, USAID/FHI, UE, GTZ, UN agencies… Decrease of the of financial participation Increasing demand

Increasing government budget

Financial participation Government subsidy con’t October 2000: ACCESS Program Levels of financial participation SES assessed by a social workers team A package including drugs, CD4 count and viral load Low income: $30- $7 per month Government officers $60- $15 About 80% of patients treated free of charge

ISAARV managerial structures Health facilities level: hospital/treatment centers Medical committees Enrollment and medical follow up PEP documentation and management Psycho-social support committees Adherence support, accompaniment counseling… PLWHA clubs Coordination level: HIV/AIDS Division, MOH Drugs and reagents management committee PMTCT management committee VCT piloting committee

Services delivery package District level : operational level Counseling, certain OI management, * PMTCT services, Referral functional system, Monitoring ARV (next step) Hospital level : district + ARV ARV entry point Rapid functionality of structures

Needs, coverage ISAARV components prior Conditions: HIV testing available/ VCT ARV Treatment Centers Counseling, treatment of OI, use of Cotrimo… Laboratories capacity : CD4, routine exams Training of health personals ARV monitoring committees

Needs, coverage (2) Monitoring ART Adults, Children, PMTCT Post Exposure Prophylaxis Psycho-social and adherence support Supportive research: Monitoring drugs resistance Promoting clinical trials

Chain of distribution National procurement pharmacy Treatment centers Regional procurement pharmacy Fann PharmacyRegional hospital/ Districts HPD, IHS

ISAARV up to date 1350 patients included Period Aout 98 - may out of 11 regions involved Active local sponsorship in process Extension to the remaining regions by end of 2003

How does the data collection work? Patient monitoring Detailed patient data base for the first 100 naives patients enrolled to the pilot phase, Database on 80 patients enrolled in the two clinical trials ANRS1204/ ANRS1206 Few initiatives on the remaining Data not being collected regularly Lack of systematized data collection

Strategic objectives Nationwide access to ARV drugs planned Strenghten capacities in the 11 regions Increasing number of PLWHA treated 7000 patients by 2006  M&E system urgently needed!!! Weak part of the program to be improved

M&E approach M&E system already in place For other priority diseases except HIV/AIDS new strategies (PMTCT, ART..) Building up process for HIV/AIDS: Capacity building** M&E Unit: NACA, MOH, and other ministries Strengthening technical resources: training

M&E approach (2) M&E plan developed Workshop in June 2003: set of indicators for each components ** (UNGASS/MAP) M&E tools and Operational guidelines to be developed training Data collection plan

M&E approach (5)

M&E approach (4) next steps by end of 2003 Workshop series Update and reinforce competencies in M&E within targeted sectors (health, education, youth…) Priority for the Health sector TOT, training series M&E tools development Data collection plan Data collection forms Defining evaluation system and calendar M&E sub- units to be set up at the regional level, Contracting services ???

Specifics needs Lack of technical resources : Urgent need to Strenghten HR capacities in M&E Recruit human resources for M&E units at each level More use of available data Systematisation of information, Regular data collection For patient monitoring and program monitoring

Specifics needs ARV delivery system to be improved Logistical issues Better planning of Evaluations for all ISAARV components Evaluation of the pilot phase (ANRS 02) More in-dept Cost-effectiveness analysis External expertise needed